menu
    • menu

    Company profile for Alpine Immune Sciences

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Alpine Immune Sciences was founded in 2015 by experts in the field of recombinant protein immunotherapies and a team responsible for the FDA approval of the world’s first cancer immunotherapy. Our directed evolution platform is based on engineering naturally-occurring immune system proteins. We modify proteins native to the immune synapse, improving them to be used as therapeutic agents for oncology, autoimmune/inflammatory ...
    Alpine Immune Sciences was founded in 2015 by experts in the field of recombinant protein immunotherapies and a team responsible for the FDA approval of the world’s first cancer immunotherapy. Our directed evolution platform is based on engineering naturally-occurring immune system proteins. We modify proteins native to the immune synapse, improving them to be used as therapeutic agents for oncology, autoimmune/inflammatory disorders, and other diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Alpine Immune SciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    201 Elliott Avenue West Suite 230 Seattle, WA 98119
    Telephone
    Telephone
    206-788-4545
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.alpineimmunesciences.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/alpine-immune-sciences
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/AlpineImmuneSci

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alpine Immune Sciences Reports First Quarter 2024 Financial Results
    Alpine Immune Sciences Reports First Quarter 2024 Financial Results

    09 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240509297301/en

    BUSINESSWIRE
    09 May 2024
    Share Share
    Vertex, Alpine’s IgAN drug has Humira-like potential. But not all indications
    Vertex, Alpine’s IgAN drug has Humira-like potential. But not all indications

    19 Apr 2024

    // Ayisha Sharma ENDPTS

    https://endpts.com/vertex-alpines-igan-drug-has-humira-like-potential-but-not-all-indications-are-created-equal/

    Ayisha Sharma ENDPTS
    19 Apr 2024
    Share Share
    Vertex Enters Into Agreement to Acquire Alpine Immune Sciences
    Vertex Enters Into Agreement to Acquire Alpine Immune Sciences

    10 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240410250636/en

    BUSINESSWIRE
    10 Apr 2024
    Share Share
    Alpine Immune Sciences, Janux said to be looking at possible sales — reports
    Alpine Immune Sciences, Janux said to be looking at possible sales — reports

    10 Apr 2024

    // Kyle LaHucik ENDPTS

    https://endpts.com/alpine-immune-sciences-janux-said-to-be-looking-at-possible-sales-reports/

    Kyle LaHucik ENDPTS
    10 Apr 2024
    Share Share
    Alpine Immune Sciences Shares Clinical Data on Povetacicept
    Alpine Immune Sciences Shares Clinical Data on Povetacicept

    09 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240410724204/en

    BUSINESSWIRE
    09 Apr 2024
    Share Share
    Alpine to Present Updated Clinical Data for Povetacicept in WCN 2024
    Alpine to Present Updated Clinical Data for Povetacicept in WCN 2024

    01 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240401672355/en

    BUSINESSWIRE
    01 Apr 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search